Sikiri, P., Petek, M., Rucman, R., Seiwerth, S., Grabarevi, Z., Rotkvi, I., Turkovi, B., Jagi, V., Mildner, B., & Duvnjak, M
Current evidence suggests: Positive Safety Indicators: No toxicity observed in animal studies at therapeutic doses Selective mechanism reduces off-target effects No evidence of organ damage or dysfunction Reversible effects upon discontinuation Areas Requiring Further Study: Long-term effects on NNMT function Impact on methylation processes over extended periods Potential effects on fertility and reproduction Interactions with aging processes Regulatory Status and Quality Considerations 5-Amino-1MQ is not FDA-approved for any medical use and exists as a research compound
07 Label and refrigerate Store upright at 2-8C (36-46F)
Are oral peptides safer than injectable peptides
the 6-10 week figure is a practitioner-derived research convention, not a clinical endpoint
In the FDA clinical studies, for instance, nine out of 10 patients had a noticeable, significant lift of the brow line